trending Market Intelligence /marketintelligence/en/news-insights/trending/h0EIHYahjYVI9G9kWY0vAw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

ReShape Lifesciences buys Apollo Endosurgery's gastric surgery products for $17M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

ReShape Lifesciences buys Apollo Endosurgery's gastric surgery products for $17M

ReShape Lifesciences Inc. has purchased Apollo Endosurgery Inc.'s surgical product line, which includes an adjustable gastric band surgically installed around the stomach for weight loss, in a cash transaction of $17 million.

ReShape Lifesciences made an up-front payment of $10 million and also gave Apollo its intragastric balloon product line, which are inflatable medical devices placed into the stomach when diet and exercise have failed and surgery is not an option.

The remaining amount will be paid to Austin, Texas-based Apollo Endosurgery in yearly installments. Apollo Endosurgery will have the legal right to get back its surgical product line until San Clemente, Calif.-based ReShape Lifesciences either makes the full payment or raises $15 million through a qualified offering.

ReShape Lifesciences develops devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders.

Cooley LLP was legal adviser to Apollo Endosurgery for the transaction, which closed Dec. 17.